Background {#Sec1}
==========

Thyroid surgeries are among the most common in the world \[[@CR1]\]. Thyroid surgery is the definitive management option for thyroid malignancies, and also for benign diseases such as multinodular goiter with compression symptoms \[[@CR2]\]. Hypocalcemia following total thyroidectomy (TT) is a relatively frequent complication, which is sometimes difficult to correct. Temporary hypocalcemia occurs in 50--68% of post-TT patients \[[@CR3], [@CR4]\], while permanent hypocalcemia occurs in 3% of post-TT patients \[[@CR5]--[@CR7]\]. Temporary hypocalcemia is defined by various authors as a post-surgery decrease in calcium (Ca), lasting for 6 to 12 months; permanent hypocalcemia is a post-TT decrease in Ca lasting for more than 12 months \[[@CR8]\]. Post-TT hypocalcemia depends on a number of factors, including biochemical blood parameters before and after surgery, clinical effects and factors related to surgery, surgical technique, surgeon's experience, the patient, and the disease \[[@CR9]\].

The aim of this study was to determine the risk factors for postoperative hypocalcemia following TT and their clinical value.

Methods {#Sec2}
=======

From January 2015 to April 2017, 400 patients underwent surgeries for various thyroid diseases at Klaipėda University Hospital, Lithuania and Vilnius University Hospital Santaros Klinikos, Lithuania. Permission from the Lithuanian Bioethics Committee was obtained for this prospective multicenter research (2014-12-02, No.: L-14-09/1, No.: L-14-09/2). All patients signed a consent form before surgery. The inclusion criteria for this study were thyroid nodules in 361 patients (90.3%), thyroid carcinoma in 84 patients (21%), thyroiditis in 37 patients (9.3%). Some patients had more than one indication for surgery. The exclusion criteria for this study were previous hemithyroidectomy, lobectomy, resection of thyroid gland, and diagnosed pathology of parathyroid glands (PGs). In this study all operations were performed by a three high-volume thyroid surgeons. Various factors that may influence post-TT hypocalcemia were investigated, including pre-operative and post-operative biochemical blood parameters, clinical effects and factors related to surgery, the patient, and the disease. Postoperative hypocalcemia was diagnosed when the level of Ca in the blood was \<2.10 mmol/L. Before surgery, Ca, ionized calcium (iCa), parathyroid hormone (PTH), 25-hydroxyvitamin D (25-hydroxy Vit D), and thyroid hormones were measured. Length of stay in hospital for patients following the surgery was 2 days. Measurements following TT on the first and second day at six oʼclock in the morning were performed. On day one following the surgery, Ca, iCa, and PTH were measured. On day two following the surgery, Ca, iCa were measured. Clinical expression of post-operative hypocalcemia, and the time when the disease manifested, were assessed. The impact of surgery-related factors on post-operative hypocalcemia was analyzed, including the number of PGs observed during the surgery, number of autotransplanted PGs, and ligation of vessels supplying blood to the thyroid gland. Oral Ca with/without calcitriol were not routinely given unless patients had symptoms or serum Ca \< 2 mmol/L. Oral Ca 1500--3000 mg with/without calcitriol 0.25 mcg twice daily were appointed for 2 weeks following the surgery. Calcitriol should be given in case a higher risk of postoperative hypocalcemia, including recurrent neck surgery, central neck dissection, intraoperative PG injury, autotransplanted PGs, also for patients with low postoperative PTH and 25-hydroxy Vit D deficiency.

All blood samples were taken from a peripheral vein. 25-hydroxy Vit D and PTH were measured with Cobas e411 analyzer (Roche Diagnostics, Mannheim, Germany). The normal range of 25-hydroxy Vit D in the blood is 75.00--106.75 nmol/L for men and 75.00--124.75 nmol/L for women. The normal PTH range is 15.00--65.00 pg/mL. The level of Ca and iCa was determined with Architect ci8200 analyzer (Abbot, Wiesbaden, Germany).

The normal range of Ca in the blood is 2.10--2.55 mmol/L and the normal range of iCa in the blood is 1.00--1.30 mmol/L.

Statistical analysis {#Sec3}
--------------------

Data analysis was performed using SPSS version 24.0 and MS Excel 2016. Univariate descriptive statistics were performed for the continuous data. Categorical data were summarized as frequencies and percentages. The chi-square test or the Fishers exact test was used to estimate the associations between categorical variables. Comparison of proportions between the groups was performed using the z test. After testing for normality, parametric or non-parametric tests were performed, as required. Comparison of health variables between hypocalcemia (no (0), yes (1)) groups was performed using the Students *t* test and the Mann--Whitney test. ANOVA and the Kruskal--Wallis test was employed for comparison of two or more groups. Univariate binary logistic regression analysis was used to determine the relative significance of sociodemographic and perceived health variables as predictors of hypocalcemia. Variables associated with post-operative hypocalcemia in univariate analyses were incorporated into a multivariate logistic regression to identify independent risk factors for post-operative hypocalcemia following thyroidectomy. Multivariate logistic regression analysis, using the backward LR (Likelihood Ratio) test, was employed to remove variables with *p* \> 0.1. Odds ratios (ORs) of statistically significant predictors are presented with 95% confidence intervals (CIs). A *p* value of less than 0.05 was taken to indicate statistical significance.

Results {#Sec4}
=======

From January 2015 to April 2017, 400 patients underwent TT's. There were 349 women (87.2%) and 51 men (12.8%). The mean age was 57.2 years and the mean weight was 79.2 kg. According to the data, post-operative hypocalcemia developed in 257 patients (64.2%). Of them, 197 patients (76.7%) were diagnosed with asymptomatic hypocalcemia. Clinical symptoms were observed in 60 patients (23.3%) of the 257 patients with hypocalcemia. Numbness of fingers was observed in 58 patients (22.6% of the patients with post-operative hypocalcemia). Chvostek's signs were present in 14 patients (5.4% of the patients with post-operative hypocalcemia). Trousseau's signs were present in eight patients (3.1% of the patients with post-operative hypocalcemia). In the group of patients with post-operative hypocalcemia, one symptom was present in 44 patients (17.1%), two symptoms were present in 11 patients (4.3%), and three symptoms were observed in five patients (1.9%). See Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"} for details.Table 1Patient demographics and clinical characteristicsVariable^a^ValueGender, *n* (%)400 (100) Female349 (87.2) Male51 (12.8)Age in years, mean (SD)57.2 (13.4)Weight in kg, mean (SD)79.2 (15.8)Thyrotoxicosis before surgery, *n* (%) No277 (69.2) \<10 years105 (26.3) ≥10 years18 (4.5)Graves' disease, *n* (%) No379 (94.7) Yes21 (5.3)Recurrent goiter, *n* (%) No397 (99.2) Yes3 (0.8)Retrosternal goiter, *n* (%) No393 (98.2) Yes7 (1.8)Bone mass density, T level, *n* (%) No394 (98.5) Yes6 (1.5)Preoperative calcium, mmol/L, mean (SD)2.36 (0.10)MD (IQR)2.36 (0.12)Preoperative ionized calcium, mmol/L, mean (SD)1.06 (0.08)MD (IQR)1.04 (0.07)Preoperative PTH, ng/L (pg/mL), mean (SD)57.71 (22.27)MD (IQR)53.90 (26.63)Preoperative 25-hydroxyvitamin D, nmol/L, mean (SD)45.27 (22.03)MD (IQR)41.78 (29.72)Preoperative TSH, mlU/L, mean (SD)0.94 (1.22)MD (IQR)0.75 (1.22)Preoperative FT3, pmol/L, mean (SD)4.87 (2.36)MD (IQR)4.66 (0.84)Preoperative FT4, pmol/L, mean (SD)13.31 (2.69)MD (IQR)13.43 (2.71)Thyroidectomy without lymphadenectomy, *n* (%)400 (100) No66 (16.5) Yes334 (83.5)Thyroidectomy with one sided central lymphadenectomy, *n* (%) No344 (86.0) Yes56 (14.0)Thyroidectomy with central lymphadenectomy on both sides, *n* (%) No390 (97.5) Yes10 (2.5)Number of observed parathyroid glands, *n* (%) 02 (0.5) 18 (2.0) 297 (24.2) 3208 (52.0) 485 (21.3)Upper branch of left inferior thyroid artery, *n* (%) Non-ligation363 (90.7) Ligation37 (9.3)Lower branch of left inferior thyroid artery, *n* (%) Non-ligation366 (91.5) Ligation34 (8.5)Trunk of left inferior thyroid artery, *n* (%) Non-ligation90 (22.5) Ligation310 (77.5)Upper branch of right inferior thyroid artery, *n* (%) Non-ligation358 (89.5) Ligation42 (10.5)Lower branch of right inferior thyroid artery, *n* (%) Non-ligation366 (91.5) Ligation34 (8.5)Trunk of right inferior thyroid artery, *n* (%) Non-ligation91 (22.8) Ligation309 (77.2)Number of darkened parathyroid glands at the end of surgery, *n* (%) 0305 (76.2) 180 (20.0) 29 (2.3) 36 (1.5)Parathyroid gland hematoma, *n* (%) No379 (94.7) Yes21 (5.3)Number of autotransplanted parathyroid glands, *n* (%) 0332 (83.0) 154 (13.4) 211 (2.8) 33 (0.8)Adenomatous nodules, *n* (%) No334 (83.5) Yes66 (16.5)Colloidal nodules, *n* (%) No130 (32.5) Yes270 (67.5)Papillary carcinoma, *n* (%) No320 (80.0) Yes80 (20.0)Follicular carcinoma, *n* (%) No399 (99.7) Yes1 (0.3)Medullary carcinoma, *n* (%) No397 (99.3) Yes3 (0.8)Anaplastic carcinoma, *n* (%) No400 (100)Autoimmune thyroiditis, *n* (%) No363 (90.7) Yes37 (9.3)Calcium day one, mmol/L, mean (SD)2.12 (0.14)MD (IQR)2.11 (0.20)Ionized calcium day one, mmol/L, mean (SD)0.99 (0.08)MD (IQR)0.99 (0.10)PTH day one, ng/L (pg/mL), mean (SD)29.98 (19.46)MD (IQR)29.06 (27.61)Calcium day two, mmol/L, mean (SD)2.05 (0.16)MD (IQR)2.06 (0.22)Ionized calcium day two, mmol/L, mean (SD)0.98 (0.09)MD (IQR)0.98 (0.11)Revision for bleeding, *n* (%) No396 (99.0) Yes4 (1.0)Wound infection, *n* (%) No400 (100)Wound hematoma, *n* (%) No389 (97.2) Yes11 (2.8)Bleeding during surgery, *n* (%) No399 (99.7) Yes1 (0.3)Clinical voice hoarseness, *n* (%) No384 (96.0) Yes16 (4.0)Recurrent laryngeal nerve paralysis on one side, ORL, *n* (%) No392 (98.0) Yes8 (2.0)Recurrent laryngeal nerve paralysis on both sides, ORL, *n* (%) No400 (100)Clinical manifestation of hypocalcemia, *n* (%) None340 (85.0) Day one14 (3.5) Day two46 (11.5)Hypocalcemia without clinical manifestation, *n* (%) No203 (50.7) Yes197 (49.3)Hypocalcemia - Chvostekʼs symptoms, *n* (%) No386 (96.5) Yes14 (3.5)Hypocalcemia - Trousseau's symptoms, *n* (%) No392 (98.0) Yes8 (2.0)Hypocalcemia - Numbness of fingers, *n* (%) No342 (85.5) Yes58 (14.5)Hypocalcemia, *n* (%) No143 (35.8) Yes257 (64.2)Treatment commenced in hospital with calcium and vitamin D preparations after surgery, *n* (%) None161 (40.3) Day 115 (3.8) Day 233 (8.3) Day 35 (1.3) On discharge186 (46.5)^a^Continuous variables are presented as means and standard deviations (*SD*) & medians (*MD*) and interquartile ranges (*IQR*); categorical variables are presented as *n* (%). *PTH* Parathyroid hormone, *TSH* thyroid stimulating hormone; *FT3* free triiodothyronine, *FT4* free thyroxine, *ORL* otorhinolaryngologistTable 2Patient characteristicsVariables^a^Hypocalcemia*p* valueYesNoGender, *n* (%)257143 Female221 (63.3)128 (36.7)*χ2* = 1.02, df = 1, *p* = 0.351 Male36 (70.6)15 (29.4)Age in years, mean (SD)57.8 (13.2)56.0 (13.8)0.207Weight, kg., mean (SD)79.0 (15.2)79.5 (16.8)0.721Thyrotoxicosis before surgery, *n* (%) No170 (66.1)107 (74.8)*χ2* = 4.10, df = 2, *p* = 0.129 \<10 years76 (29.6)29 (20.3) ≥10 years11 (4.3)7 (4.9)Graves' disease, *n* (%) No241 (93.8)138 (96.5)*χ2* = 1.38, df = 1, *p* = 0.350 Yes16 (6.2)5 (3.5)Recurrent goiter, *n* (%) No254 (98.8)143 (100)*χ2* = 1.68, df = 1, *p* = 0.556 Yes3 (1.2)0Retrosternal goiter, *n* (%) No250 (97.3)143 (100)*χ2* = 3.96, df = 1, *p* = 0.053 Yes7 (2.7)0Bone mass density, T level, *n* (%) No394 (98.5)394 (98.5)*χ2* = 0.54, df = 1, *p* = 0.671 Yes6 (1.5)6 (1.5)Preoperative calcium, mmol/L, mean (SD)^b^2.35 (0.09)2.39 (0.11)\< 0.001MD (IQR)2.35 (0.11)2.39 (0.12)Preoperative ionized calcium, mmol/L, mean (SD)^b^1.04 (0.07)1.08 (0.10)\< 0.001MD (IQR)1.03 (0.07)1.07 (0.09)Preoperative PTH, ng/L (pg/mL), mean (SD)^b^57.86 (22.18)57.43 (22.50)0.855MD (IQR)54.17 (26.38)53.65 (26.05)Preoperative 25-hydroxyvitamin D, nmol/L, mean (SD)^c^44.22 (22.97)47.16 (20.17)0.053MD (IQR)40.35 (30.47)46.40 (26.69)Preoperative TSH, mlU/L, mean (SD)^c^1.12 (1.33)0.96 (0.97)0.355MD (IQR)0.80 (1.20)0.70 (1.17)Preoperative FT3, pmol/L, mean (SD)^b^4.85 (2.73)4.90 (1.50)0.854MD (IQR)4.60 (0.83)4.71 (0.93)Preoperative FT4, pmol/L, mean (SD)^b^13.53 (2.47)13.67 (3.05)0.626MD (IQR)13.45 (2.92)13.40 (2.36)Thyroidectomy without lymphadenectomy, *n* (%) No48 (18.7)18 (12.6)*χ2* = 2.47, df = 1, *p* = 0.124 Yes209 (81.3)125 (87.4)Thyroidectomy with one sided central lymphadenectomy, *n* (%) No216 (84.0)128 (89.5)*χ2* = 2.28, df = 1, *p* = 0.175 Yes41 (16.0)15 (10.5)Thyroidectomy with central lymphadenectomy on both sides, *n* (%) No250 (97.3)140 (97.9)*χ2* = 0.15, df = 1, *p* = 1.000 Yes7 (2.7)3 (2.1)Number of observed parathyroid glands, *n* (%) 02 (0.8)0*χ2* = 35.23, df = 4, *p* \< 0.001 13 (1.2)5 (3.5) 276 (29.6)^\*\*^21 (14.7)^\*\*^ 3142 (55.3)66 (46.2) 434 (13.2)^\*\*\*^51 (36.7)^\*\*\*^Upper branch of left inferior thyroid artery, *n* (%) Non-ligation231 (89.9)132 (92.3)*χ2* = 0.64, df = 1, *p* = 0.475 Ligation26 (10.1)11 (7.7)Lower branch of left inferior thyroid artery, *n* (%) Non-ligation232 (90.3)134 (93.7)*χ2* = 1.39, df = 1, *p* = 0.267 Ligation25 (9.7)9 (6.3)Trunk of left inferior thyroid artery, *n* (%) Non-ligation46 (17.9)44 (30.8)*χ2* = 8.73, df = 1, *p* = 0.003 Ligation211 (82.1)99 (69.2)Upper branch of right inferior thyroid artery, *n* (%) Non-ligation232 (90.3)126 (88.1)*χ2* = 0.46, df = 1, *p* = 0.501 Ligation25 (9.7)17 (11.9)Lower branch of right inferior thyroid artery, *n* (%) Non-ligation231 (89.9)135 (94.4)*χ2* = 2.42, df = 1, *p* = 0.137 Ligation26 (10.1)8 (5.6)Trunk of right inferior thyroid artery, *n* (%) Non-ligation44 (17.1)47 (32.9)*χ2* = 12.96, df = 1, *p* \< 0.001 Ligation213 (82.9)96 (67.1)Number of darkened parathyroid glands at the end of surgery, *n* (%) 0194 (75.5)111 (77.6)*χ2* = 3.64, df = 3, *p* = 0.303 154 (21.0)26 (18.2) 27 (2.7)2 (1.4) 32 (0.8)4 (2.8)Parathyroid gland hematoma, *n* (%) No244 (94.9)135 (94.4)*χ2* = 0.05, df = 1, *p* = 0.818 Yes13 (5.1)8 (5.6)Number of autotransplanted parathyroid glands, *n* (%) 0205 (79.8)^\*^127 (88.8)^\*^*χ2* = 6.32, df = 3, *p* = 0.097 140 (15.6)14 (9.8) 29 (3.5)2 (1.4) 33 (1.2)0Adenomatous nodules, *n* (%) No218 (84.8)116 (81.1)*χ2* = 0.92, df = 1, *p* = 0.399 Yes39 (15.2)27 (18.9)Colloidal nodules, *n* (%) No81 (31.5)49 (34.3)*χ2* = 0.32, df = 1, *p* = 0.579 Yes176 (68.5)94 (65.7)Papillary carcinoma, *n* (%) No203 (79.0)142 (99.3)*χ2* = 0.46, df = 1, *p* = 0.518 Yes54 (21.0)26 (18.2)Follicular carcinoma, *n* (%) No257 (100)399 (99.3)*χ2* = 1.80, df = 1, *p* = 0.358 Yes01 (0.7)Medullary carcinoma, *n* (%) No254 (98.8)143 (100)*χ2* = 1.68, df = 1, *p* = 0.556 Yes3 (1.2)0Anaplastic carcinoma, *n* (%) No257 (100)143 (100)Autoimmune thyroiditis, *n* (%) No234 (91.1)129 (90.2)*χ2* = 0.08, df = 1, *p* = 0.857 Yes23 (8.9)14 (9.8)Calcium day one, mmol/L, mean (SD)2.05 (0.12)2.24 (0.11)\< 0.001MD (IQR)2.05 (0.16)2.25 (0.13)Ionized calcium day one, mmol/L, mean (SD)0.96 (0.07)1.06 (0.07)\< 0.001MD (IQR)0.96 (0.08)1.05 (0.09)PTH, ng/L (pg/mL), mean (SD)24.42 (18.27)39.97 (17.50)\< 0.001MD (IQR)21.47 (29.24)38.09 (20.86)Calcium day two, mmol/L, mean (SD)1.96 (0.12)2.20 (0.08)\< 0.001MD (IQR)1.99 (0.18)2.19 (0.11)Ionized calcium day two, mmol/L, mean (SD)0.94 (0.07)1.06 (0.07)\< 0.001MD (IQR)0.94 (0.09)1.05 (0.08)Revision for bleeding, *n* (%) No254 (98.8)142 (99.3)*χ2* = 0.20, df = 1, *p* = 1.000 Yes3 (1.2)1 (0.7)Wound infection, *n* (%) No257 (100)143 (100)Wound hematoma, *n* (%) No249 (96.9)140 (97.9)*χ2* = 0.35, df = 1, *p* = 0.753 Yes8 (3.1)3 (2.1)Bleeding during surgery, *n* (%) No256 (99.6)143 (100)*χ2* = 0.56, df = 1, *p* = 1.000 Yes1 (0.4)0Clinical voice hoarseness, *n* (%) No245 (95.3)139 (97.2)*χ2* = 0.84, df = 1, *p* = 0.434 Yes12 (4.7)4 (2.8)Recurrent laryngeal nerve paralysis on one side, ORL, *n* (%) No252 (98.1)140 (97.9)*χ2* = 0.84, df = 1, *p* = 0.434 Yes5 (1.9)3 (2.1)Recurrent laryngeal nerve paralysis on both sides, ORL, *n* (%) No257 (100)143 (100)Clinical manifestation of hypocalcemia, *n* (%) None197 (76.7)143 (100)*χ2* = 39.27, df = 2, *p* \< 0.001 Day 114 (3.5)0 Day 246 (17.9)0Hypocalcemia without clinical manifestation, *n* (%) No60 (23.3)143 (100)*χ2* = 215.99, df = 1, *p* \< 0.001 Yes197 (76.7)0Hypocalcemia - Chvostekʼs symptoms, *n* (%) No243 (94.6)143 (100)*χ2* = 8.07, df = 1, *p* = 0.004 Yes14 (5.4)0Hypocalcemia - Trousseau's symptoms, *n* (%) No249 (96.9)143 (100)*χ2* = 4.54, df = 1, *p* = 0.033 Yes8 (2.0)0Hypocalcemia - Numbness of fingers, *n* (%) No199 (77.4)143 (100)*χ2* = 37.75, df = 1, *p* \< 0.001 Yes58 (22.6)0Treatment commenced in hospital with calcium and vitamin D preparations after surgery, *n* (%) None23 (8.9)139 (97.2)*χ2* = 297.04, df = 4, *p* \< 0.001 Day 115 (5.8)0) Day 233 (12.8)0 Day 35 (1.9)0 On discharge181 (70.3)4 (2.8)^a^Continuous variables are presented as means and standard deviations (*SD*) & medians and interquartile ranges (*IQR*); categorical variables are presented as *n* (%). ^b^Student t test; ^c^Mann-Whitney U test. ^\*^ *p* \< 0.05, z test, ^\*\*^ *p* \< 0.01, ^\*\*\*^ *p* \< 0.001. *PTH* Parathyroid hormone, *ORL* otorhinolaryngologist

Comparison of the patients with diagnosed hypocalcemia following surgery and the patients without diagnosis of hypocalcemia showed that the following variables were significantly related to the development of hypocalcemia: decreased pre-operative Ca (*p* \< 0.001), and decreased pre-operative iCa (*p* \< 0.001). Our study did not showed an increased risk of postoperative hypocalcemia in the case of malignancy: papillary carcinoma (*p* = 0.518), follicular carcinoma (*p* = 0.358), medullary carcinoma (*p* = 0.556), and bilateral central neck dissection (*p* = 1.000), wound hematoma (*p* = 0.753), bleeding during surgery (*p* = 1.000), revision for bleeding (*p* = 1.000). These data are presented in Table [2](#Tab2){ref-type="table"}.

Univariate analysis revealed that thyrotoxicosis \<10 years before surgery was a predisposing factor for hypocalcemia (OR 1.65, 95% CI 1.01--2.70, *p* = 0.046). The number of PGs observed during surgery was also statistically associated with post-operative hypocalcemia (OR 0.52, 95% CI 0.38--0.70, *p* \< 0.001). Ligation of the trunk of the left inferior thyroid artery (OR 2.04, 95% CI 1.27--3.29, *p* = 0.003) and the trunk of the right inferior thyroid artery (OR 2.37, 95% CI 1.47--3.82, *p* \< 0.001) were statistically significant factors related to post-operative hypocalcemia. The number of PGs autotransplanted during surgery was also significantly associated with post-TT hypocalcemia (OR 1.87, 95% CI 1.12--2.97, *p* = 0.015). Finally, PTH on day one following the surgery was a statistically significant predictor of post-operative hypocalcemia (OR 0.96, 95% CI 0.94--0.97, *p* \< 0.001). This data is presented in Table [3](#Tab3){ref-type="table"}.Table 3Associations between patient characteristics and risk of hypocalcemia - Univariate modelVariableOR95% CI*p*Thyrotoxicosis before surgery: no10.132\<10 years1.651.01--2.700.046\>10 years0.990.37--2.630.982Thyroidectomy without lymphadenectomy0.630.35--1.130.118Thyroidectomy with one sided central lymphadenectomy1.620.86--3.040.134Thyroidectomy with central lymphadenectomy on both sides1.310.33--5.130.702Upper branch of left inferior thyroid artery, ligation0.740.35--1.550.424Lower branch of left inferior thyroid artery, ligation0.620.28--1.380.241Trunk of left inferior thyroid artery, ligation2.041.27--3.290.003Upper branch of right inferior thyroid artery, ligation1.250.65--2.410.500Lower branch of right inferior thyroid artery, ligation1.900.84--4.310.125Trunk of right inferior thyroid artery, ligation2.371.47--3.82\<0.001Number of darkened parathyroid glands at the end of surgery0.980.69--1.390.925Parathyroid gland hematoma0.900.36--2.220.818Adenomatous nodules0.770.45--1.320.339Colloidal nodules1.130.73--1.750.574Papillary carcinoma1.200.71--2.010.498Autoimmune thyroiditis0.910.45--1.820.781Graves' disease0.550.20--1.520.247Calcium before surgery0.011.01--0.57\<0.001Calcium, day 1 after surgery0.000.00--0.00\<0.001Calcium, day 2 after surgery0.000.00--0.00\<0.001Ionized calcium before surgery0.0010.000--0.013\<0.001Ionized calcium, day 1 after surgery0.000.00--0.00\<0.001Ionized calcium, day 2 after surgery0.000.00--0.00\<0.001PTH before surgery1.000.99--1.010.854PTH, day 1 after surgery0.960.94--0.97\<0.00125-hydroxyvitamin D before surgery0.990.99--1.000.201TSH before surgery1.130.94--1.360.197FT4 before surgery0.980.91--1.060.625FT3 before surgery0.990.91--1.080.854*PTH* Parathyroid hormone, *TSH* thyroid stimulating hormone, *FT3* free triiodothyronine, *FT4* free thyroxine

Unlike the univariate analysis, multivariate analysis revealed that older age (OR 1.05, 95% CI 1.01--1.09, *p* = 0.029) and female gender (OR 5.94, 95% CI 1.13--31.26, *p* = 0.035) were statistically significant independent predictors of post-operative hypocalcemia. See Table [4](#Tab4){ref-type="table"}.Table 4Associations between patient characteristics and risk of hypocalcemia - Multivariate modelVariableOR95% CI*p*Age1.051.01--1.090.029Gender5.941.13--31.260.035Calcium, second day after surgery0.000.00--0.00\<0.001*OR* Odds ratio, *CI* confidence interval

Discussion {#Sec5}
==========

Post-TT hypocalcemia is one of the most common complications \[[@CR10]\]. According to the literature, post-TT hypocalcemia occurs in 50--68% of patients \[[@CR3], [@CR4]\]. In our study, post-TT hypocalcemia developed in 64.2% of the patients. In the literature, the majority of patients exhibit asymptomatic hypocalcemia and need no treatment, or only oral administration of Ca and vitamin D preparations \[[@CR11]\]. In our study, 197 patients had asymptomatic hypocalcemia (49.3% of all the patients who participated in the study, or 76.7% of the patients with post-operative hypocalcemia). Less than half of the patients received no treatment after TT (161; 40.3%). The patients who received treatments were prescribed oral or intravenous preparations of Ca and vitamin D, depending on the time of expression and intensity of clinical symptoms (Table [2](#Tab2){ref-type="table"}). Overall, 60 patients (15% of all the patients who participated in the study, or 23.3% of the patients with post-operative hypocalcemia) had one, two, or three clinical symptoms of hypocalcemia. In a multicenter study with 14,934 patients, Rosato et al. found that 10% of patients had symptomatic hypocalcemia \[[@CR3]\]. However, that study included patients who had TT (64.3%) and smaller-scale surgeries on the thyroid (35.7%) \[[@CR3]\]. In our study, decreased pre-operative Ca and iCa were statistically significant predictors of post-operative hypocalcemia (*p* \< 0.001). Several studies have found that temporary post-operative hypocalcemia develops more often in patients who have a markedly decreased level of Ca before surgery \[[@CR12]--[@CR18]\]. However, a meta-analysis of six studies with 2493 patients did not reveal a statistically reliable association between pre-operative Ca and the frequency of temporary hypocalcemia \[[@CR17]--[@CR21]\]. A sharp decrease in Ca after TT is associated with temporary hypocalcemia \[[@CR12], [@CR22]--[@CR24]\]. In a multicenter study with 1157 patients, Hallgrimsson et al. found that patients who experienced a 2--3% decrease in post-operative Ca in the 24 h following surgery, in comparison with the pre-operative level of Ca, had a 94% chance of developing temporary hypocalcemia \[[@CR25]\]. Changes in the levels of Ca in the blood during the first 24 h following surgery allow prediction of temporary hypocalcemia with 19--91% sensitivity \[[@CR26]--[@CR30]\]. A blood Ca concentration of 1.88 mmol/L or less during the first 24 h after surgery has been associated with permanent hypocalcemia \[[@CR31]\]. Two other studies have demonstrated that there is an increased risk of developing permanent hypocalcemia if the level of Ca in the blood remains at 2 mmol/L or less, 1--3 weeks after surgery \[[@CR32], [@CR33]\]. Tartaglia et al. revealed that measurement of iCa was more reliable than measurement of Ca in post-TT patients, in the immediate and long-term follow-up \[[@CR34]\].

Based on our data, decreased PTH during the first 24 h after surgery was a statistically reliable predictor of post-operative hypocalcemia (*p* \< 0.001). In many other studies, a decrease in blood PTH following TT was found to result in possible development of temporary hypocalcemia \[[@CR12], [@CR35]--[@CR39]\]. The systematic overview and meta-analysis conducted by Edafe et al. showed that patients with a decrease in post-operative PTH, to a level of 6--35 pg/mL, 1 h to 1 day following surgery, had a 69--100% chance of developing temporary hypocalcemia \[[@CR9]\].

According to our data, the number of PGs identified during the surgery was a statistically significant predictor of the development of hypocalcemia. The greater the number of PGs found during surgery, the lower the chance of hypocalcemia. The study by Thomusch et al. determined that permanent post-operative hypocalcemia was more likely to develop if less than two PGs were found during surgery \[[@CR40]\]. On the other hand, other studies have found that more PGs found during surgery may be associated with temporary hypocalcemia \[[@CR12], [@CR25], [@CR41]\].

In our study, the number of PGs autotransplanted during surgery was a statistically reliable predictor of the development of post-TT hypocalcemia (*p* = 0.015). The greater the number of autotransplanted PGs, the higher the chance of hypocalcemia. Several studies have shown that autotransplantation of one or more PGs results in a far higher chance of hypocalcemia \[[@CR12], [@CR17], [@CR18], [@CR42]\]. However, several other studies showed no association between autotransplantation of PGs and permanent hypocalcemia \[[@CR18], [@CR25], [@CR31], [@CR43]\].

In our study, thyrotoxicosis \<10 years before surgery was found to be a statistically reliable predictor of post-TT hypocalcemia (*p* = 0.046). Thyrotoxicosis \>10 years before surgery was not significantly associated with post-TT hypocalcemia (*p* = 0.982); however, there were only 18 such patients (4.5%) in our study. Based on our data, Graves' disease was not a statistically significant predictor of post-TT hypocalcemia (*p* = 0.247), but again, it was only diagnosed in 21 patients (5.3%). The multivariate analysis by Thomusch et al. demonstrated that, in patients with Graves' disease, both temporary and permanent hypocalcemia developed more often following TT \[[@CR40]\]. Further, a meta-analysis of four studies with 6681 patients showed a greater frequency of post-operative temporary hypocalcemia in patients with Graves' disease \[[@CR40], [@CR44]--[@CR46]\].

Ligation of the trunk of the left inferior thyroid artery (*p* = 0.003) and the trunk of the right inferior thyroid artery (*p* \< 0.001) were found to be statistically reliable predictors of hypocalcemia in our study. In a study of 1411 patients, Park et al. found that saving vessels supplying blood to the thyroid gland during surgery reduced the frequency of both temporary and permanent hypocalcemia in univariate (*p* = 0.01) and multivariate (*p* = 0.02) analyses \[[@CR47]\]. According to Lee et al., saving veins on both sides of the thyroid may reduce post-TT hypocalcemia \[[@CR48]\]. It has long been accepted that post-TT hypocalcemia depends on the experience of the surgeon and the surgical technique used \[[@CR49], [@CR50]\]. Our study identified some risk factors related to the surgical technique; hence, it is important not only to identify important factors following surgery that may influence development of hypocalcemia, but also to reconsider the surgical technique in order to minimize this risk, if possible.

In our study, the frequency analysis showed that neither gender (*p* = 0.351) nor age (*p* = 0.207) had a significant impact on development of hypocalcemia. However, in the multivariate analysis, female gender (*p* = 0.035) and older age (*p* = 0.029) were statistically significant predictors. There is no definitive evidence on the impact of age on the development of post-operative hypocalcemia in the literature. Some studies suggest that temporary post-operative hypocalcemia is more common in younger patients \[[@CR15], [@CR25]\], while others suggest it is more common in older patients \[[@CR19], [@CR21]\]. A meta-analysis of five studies with 2576 patients revealed no significant association between patient age and temporary hypocalcemia \[[@CR15], [@CR17]--[@CR19], [@CR21]\]. While a meta-analysis of 10 studies involving 3443 patients showed that temporary post-operative hypocalcemia was more common in women \[[@CR12], [@CR15], [@CR17]--[@CR21], [@CR23], [@CR41], [@CR51]\].

Conclusions {#Sec6}
===========

This study demonstrates that there is a number of different patient (gender, age, and thyrotoxicosis \<10 years before surgery) and surgical (number of PGs found observed surgery, decreased Ca and iCa before surgery, PTH on day one following surgery, and ligation of the trunk of the left and right inferior thyroid artery) risk factors predictive of the development of hypocalcemia following TT. Our study suggests that it is important not only to identify factors following surgery that may predict development of hypocalcemia, but also to reconsider the surgical technique, in order to minimize this risk, if possible. Identification of known risk factors post-operatively could allow for early detection and effective treatment of these patients.
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